Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

S. M. Kim, H. Kim, M. R. Yun, H. N. Kang, K. H. Pyo, H. J. Park, J. M. Lee, H. M. Choi, P. Ellinghaus, M. Ocker, S. Paik, H. R. Kim, B. C. Cho

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science